99 related articles for article (PubMed ID: 15673775)
1. In vitro antileishmanial activity of nicotinamide.
Sereno D; Alegre AM; Silvestre R; Vergnes B; Ouaissi A
Antimicrob Agents Chemother; 2005 Feb; 49(2):808-12. PubMed ID: 15673775
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of nicotinamide/antileishmanial drug combinations.
Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
[TBL] [Abstract][Full Text] [Related]
3. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
4. Leishmania major and Leishmania tropica: II. Effect of an immunomodulator, S(2) complex on the enzymes of the parasites.
Al-Mulla Hummadi YM; Al-Bashir NM; Najim RA
Exp Parasitol; 2006 Feb; 112(2):85-91. PubMed ID: 16274690
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth.
Prusty D; Mehra P; Srivastava S; Shivange AV; Gupta A; Roy N; Dhar SK
FEMS Microbiol Lett; 2008 May; 282(2):266-72. PubMed ID: 18397290
[TBL] [Abstract][Full Text] [Related]
6. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural alterations and growth inhibition of Trypanosoma cruzi and Leishmania major induced by Bothrops jararaca venom.
Gonçalves AR; Soares MJ; de Souza W; DaMatta RA; Alves EW
Parasitol Res; 2002 Jul; 88(7):598-602. PubMed ID: 12107450
[TBL] [Abstract][Full Text] [Related]
8. Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase.
Vergnes B; Vanhille L; Ouaissi A; Sereno D
Acta Trop; 2005 May; 94(2):107-15. PubMed ID: 15860278
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide induces Fob1-dependent plasmid integration into chromosome XII in Saccharomyces cerevisiae.
Tripathi K; Matmati N; Zzaman S; Westwater C; Mohanty BK
FEMS Yeast Res; 2012 Dec; 12(8):949-57. PubMed ID: 22909099
[TBL] [Abstract][Full Text] [Related]
10. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
[TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity of HIV protease inhibitors.
Savoia D; Allice T; Tovo PA
Int J Antimicrob Agents; 2005 Jul; 26(1):92-4. PubMed ID: 15955671
[TBL] [Abstract][Full Text] [Related]
12. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
Sauve AA; Schramm VL
Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
[TBL] [Abstract][Full Text] [Related]
13. In vitro antileishmanial activity of resveratrol originates from its cytotoxic potential against host cells.
Lucas IK; Kolodziej H
Planta Med; 2013 Jan; 79(1):20-6. PubMed ID: 23225365
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial and antibacterial activity of a new pyrazole derivative designated 4-[2-(1-(ethylamino)-2-methyl- propyl)phenyl]-3-(4-methyphenyl)-1-phenylpyrazole.
Dardari Z; Lemrani M; Sebban A; Bahloul A; Hassar M; Kitane S; Berrada M; Boudouma M
Arch Pharm (Weinheim); 2006 Jun; 339(6):291-8. PubMed ID: 16619283
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by Dications of in vitro growth of Leishmania major and Leishmania tropica: causative agents of old world cutaneous leishmaniasis.
Rosypal AC; Werbovetz KA; Salem M; Stephens CE; Kumar A; Boykin DW; Hall JE; Tidwell RR
J Parasitol; 2008 Jun; 94(3):743-9. PubMed ID: 18605790
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis.
Eissa MM; Amer EI; El Sawy SM
Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment.
Peled T; Shoham H; Aschengrau D; Yackoubov D; Frei G; Rosenheimer G N; Lerrer B; Cohen HY; Nagler A; Fibach E; Peled A
Exp Hematol; 2012 Apr; 40(4):342-55.e1. PubMed ID: 22198152
[TBL] [Abstract][Full Text] [Related]
18. Structure activity relationship studies on antileishmanial steroidal alkaloids from Sarcococca hookeriana.
Devkota KP; Choudhary MI; Ranjit R; Samreen ; Sewald N
Nat Prod Res; 2007 Apr; 21(4):292-7. PubMed ID: 17479416
[TBL] [Abstract][Full Text] [Related]
19. The mechanism behind the antileishmanial effect of zinc sulphate. II. Effects on the enzymes of the parasites.
Al-Mulla Hummadi YM; Al-Bashir NM; Najim RA
Ann Trop Med Parasitol; 2005 Mar; 99(2):131-9. PubMed ID: 15814032
[TBL] [Abstract][Full Text] [Related]
20. Sir2-Related Protein 1 from Leishmania amazonensis is a glycosylated NAD+-dependent deacetylase.
Fessel MR; Lira CB; Giorgio S; Ramos CH; Cano MI
Parasitology; 2011 Sep; 138(10):1245-58. PubMed ID: 21819639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
